These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 16169864)

  • 21. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
    Cozzolino M; Dusso AS; Liapis H; Finch J; Lu Y; Burke SK; Slatopolsky E
    J Am Soc Nephrol; 2002 Sep; 13(9):2299-308. PubMed ID: 12191974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
    Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
    Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
    Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
    Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients.
    Burke SK; Dillon MA; Hemken DE; Rezabek MS; Balwit JM
    Adv Ren Replace Ther; 2003 Apr; 10(2):133-45. PubMed ID: 12879374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment with phosphate binder (sevelamer hydrochloride, calcium carbonate) based on PTH].
    Sato M; Fukazawa S; Yasuda T; Akatsuka T; Tozawa S; Niida Y; Hashimoto N; Mochizuki T; Koike T
    Clin Calcium; 2005 Sep; 15 Suppl 1():23-8; discussion 28-9. PubMed ID: 16272625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful kidney transplantation reduces hyperplastic parathyroid gland.
    Bravo J; Esteban RJ; Medina A; Palacios ME; Pérez A; Perán F; de Dios Luna J; González J; Prados MD; Asensio C
    Transplant Proc; 2007; 39(1):125-31. PubMed ID: 17275488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Defining the role of sevelamer chloride as a therapeutic agent for management of phosphate in patient with hemodialysis].
    Hashimoto N; Miyata M; Sato N; Mochizuki T; Koike T
    Clin Calcium; 2005 Sep; 15 Suppl 1():30-4; discussion 34. PubMed ID: 16272626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus.
    Yi H; Fukagawa M; Yamato H; Kumagai M; Watanabe T; Kurokawa K
    Nephron; 1995; 70(2):242-8. PubMed ID: 7566311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism.
    Yamada S; Tokumoto M; Taniguchi M; Toyonaga J; Suehiro T; Eriguchi R; Fujimi S; Ooboshi H; Kitazono T; Tsuruya K
    Ther Apher Dial; 2015 Aug; 19(4):367-77. PubMed ID: 25851690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.
    Shiizaki K; Negi S; Hatamura I; Sakaguchi T; Saji F; Kunimoto K; Mizobuchi M; Imazeki I; Ooshima A; Akizawa T
    J Am Soc Nephrol; 2005 Jan; 16(1):97-108. PubMed ID: 15574509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate.
    Brown AJ; Ritter CS; Finch JL; Slatopolsky EA
    Kidney Int; 1999 Apr; 55(4):1284-92. PubMed ID: 10200992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal mineral handling in normal rats treated with sevelamer hydrochloride (Renagel), a noncalcemic phosphate binder.
    Nagano N; Miyata S; Obana S; Eto N; Fukushima N; Burke SK; Wada M
    Nephron; 2001 Nov; 89(3):321-8. PubMed ID: 11598397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genistein affects parathyroid gland and NaPi 2a cotransporter in an animal model of the andropause.
    Pantelic J; Ajdzanovic V; Medigovic I; Mojic M; Trifunovic S; Milosevic V; Filipovic B
    J Physiol Pharmacol; 2013 Jun; 64(3):361-8. PubMed ID: 23959733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.
    Mizobuchi M; Hatamura I; Ogata H; Saji F; Uda S; Shiizaki K; Sakaguchi T; Negi S; Kinugasa E; Koshikawa S; Akizawa T
    J Am Soc Nephrol; 2004 Oct; 15(10):2579-87. PubMed ID: 15466262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sevelamer therapy for pediatric end-stage renal disease.
    Storms LE; Chicella MF; Dice JE
    Pharmacotherapy; 2006 Mar; 26(3):410-3. PubMed ID: 16503722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of sevelamer on mineral metabolism and hyperparathyroidism in Japanese hemodialysis patients.
    Inoue T; Nagatoya K; Kagitani M; Shibahara N; Ueda H; Katsuoka Y; Ohashi S; Kitagawa Y; Nishimoto K; Yasuda H;
    Ther Apher Dial; 2007 Jun; 11(3):210-4. PubMed ID: 17498003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sevelamer hydrochloride prevents ectopic calcification of blood vessels].
    Fukushima N; Nagano N
    Clin Calcium; 2004 Jun; 14(6):116-22. PubMed ID: 15577065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.
    Moe SM; Radcliffe JS; White KE; Gattone VH; Seifert MF; Chen X; Aldridge B; Chen NX
    J Bone Miner Res; 2011 Nov; 26(11):2672-81. PubMed ID: 21826734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.